110木村班GL念校.indd

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "110木村班GL念校.indd"

Transcription

1 1

2 2012 2

3 ST 2013 acute coronary syndrome: ACS ST ST 3 3 ST ST 2012 ST percutaneous coronary interventionpci magnetic resonance imaging MRI universal definition 99 1) ST ST 12 ST ST

4 2012 ST ST I II IIa IIb III A400 B400 C Davies 2) Fuster 3) acute coronary syndromeacs ST ST-elevation acute myocardial infarctionstemi 4

5 ST

6 ) 1980 DeWood 5) Kodama 6) 92 Asakura 7) T vulnerable plaque 8,9) calcified nodule calcified nodule 10) positive remodeling T T 10) 11) optical coherence tomographyoct 12) 13) OCT fibrous cap thin fibrous cap fibroatheroma TCFA 14) 7) vulnerable patient 15) 40 16) 17) universal definition 1 2 1) 6

7 ST 2013 STEMI hypokinesis akinesis dyskinesis 18) dp/dt 19) 1 Frank-Starling 20) angiotensin converting enzymeace 21) BNP 22) STEMI 6 3) Hurler Fabry CO DIC 23) 17,24,25) 26,27) ,29) NIPPON DATA National Integrated Project for Prospective Obser vation of Non-communicable Disease And its Trends in the Aged 30) HDL 135 mmhg 85 mmhg 2 7

8 ) 32) ) 34) 35) 36) 37) ) 39) LDL 40,41) ) J-LITJapan Lipid Intervention Trial 43) 44) CKD 45) CKD 46) CKD 47) Ni-Hon-San 48) 49,50) 51) 52) ) ) ) STEMI 56) ) MIYAGI- AMI Registry ) OASIS ) 2005 HIJAMI ) MIYAGI-AMI Registry ) CCU ) 8

9 ST ) STEMIcoronary care unitccu 7 59) STEMI CCU STEMI ) STEMI 63,64) door-to-balloon time onset-to-device time onsetto-device time STEMI ) ACC/ AHA STEMI CCU ) STEMI STEMI STEMI 14 ventricular fibrillationvf VF 60 61) automated external defibrillatoraed 12 69) AED AED 62) AED 9

10 cardiopulmonary resuscitationcpr CPR CPR CPR 70,71) 2010 ILCOR CoSTR AHA CPR BLSbasic life support CPR AED STEMI 66-68,72) ,74) AED 1 mg/ ,74) 73,74) 10

11 ST IV. 14 STEMI 75-77) CI ) AHA CPR/ECC 2010 PCI 90 79) Watanabe TIMI ) Nakao 2 facilitated PCI TIMI 3 81) Kimura primary PCI 90 TIMI 3 68 primary PCI 43 82) 30 PCI 2 PCI 83, 84). AHA/ACC ST /PCI 2009 PCI primary PCI PCI PCI PCI 85) 11

12 2012 STEMI PCI CABG STEMI TIMI PCI 12 86,87) 12 CCU 24 CCU STEMI 12

13 ST ) STEMI STEMI PCI CABG CCU CCU 13

14 2012 STEMI ) 12 STEMI 30 PCI first medical contact ) STEMI 95-98) 20 14

15 ST ) 100) 97,98) Ca 101) 15

16 Bezold-Jarisch 90 mmhg III III Killip 102) thrill 4 23 III Killip 102) STEMI Stanford A 5 16

17 ST 2013 STEMI 103) 104,105) Thyperacute T T R ST Q STEMI 106) 510 V4R V4R 1mm 0.1mV ST ST 10 ST 107) STEMI ST ST 108,109) ST V1V4 ST V7V9 ST ST T ) ST 114) V1V3 ST QS ST avr ST PR avr ST PR WPWWolff- Parkinson-White 2 ST-T QRS 1mm ST V1V3 1mm ST QRS 5mm ST STEMI 115) V1 V3V4 ST qr V1 rr R 116) avr ST V1 ST 117). 12 Cabrera sequence 118) avl I avr avr III II Cabrera sequence 12 STEMI 119) STEMI 12 17

18 ,121) primary PCI PCI ) 12 STEMI ) STEMI 131) creatine kinaseckmbck-mb H-FABP TI T 6 STEMI I 132) CK 133,134) 135) STEMI CK CK 99 CK ESC/ACCF/AHA/WHF universal definition 136,137) 2 138) 2 139,140) H-FABP H-FABP H-FABP 2 141) 142) 18

19 ST 2013 X X X X X ,144) echo free space diastolic 19

20 2012 collapse Doppler intimal flap STEMI STEMI ) Killip 102) Killip IV a) mmhg 90 mmhg SHOCK Registry b) GRACE TIMI GRACE Killip ST STEMI 6 152,153) GRACE GRACE ) TIMI 8 155) GRACE TIMI simple risk indexcadillac simple risk index / ) CADILAC PCI Killip 3 PCI TIMI 7 157) STEMI 20

21 ST ) 159) L/ CO2 160) 161) 162) mmhg 30 mmhg50/ 100/ ) 24 mg mg 21

22 mg mg ) STEMI mg 81 mg mg 23 PCI 2 loading dose300 mg 172,173) 600 mg 174) 75 mg/ 85,175,176) ) PCI ACT TIMI 2 178) tpa 179,180) tpa APTT V ,182) 22

23 ST 2013 heparin-induced thrombocytopenia: HIT 183,184) immune-mediated HIT II HIT 1 HIT 185) HIT HIT 186) ) 2 192) PCI ) 194) PCI 195) ,197) VI. 38 PCI STEMI 6 5) Fabry Hurler 23

24 2012 CO DIC 23) Stanford A 39 STEMI Marfan B A X STEMI intimal flap CT intimal flap A 198) STEMI , 200) STEMI ) ) coronary artery bypass graftingcabg 201) intravascular ultrasound IVUSOCT ST universal definition 2 1) ) 202) Prizel ) ) 207,208) PCI 1970 universal definition 2 1) 24

25 ST ) 210) Ueda 211) STEMI A 212) 213) P- 214) ,216) 69 17) ) STEMI STEMI Ca STEMI ) Fabry 23) STEMI PCI 64,72) first medical contact door-to-needle time 30 PCI first medical contact door-to-device time 90 PCI PCI 3 PCI 217,218) PCI PCI PCI 60 PCI 60 94) 25

26 2012 PCI PCI STEMI 219) 60PCI 3 PCI 217,218) STEMI PCI PCI 219) 10 57,220) PCI universal definition STEMI ST 26

27 ST /110 mmhg ST PCI /kg TIMI 2 PCI 27

28 kg mL 1 PCI PCI PCI primary PCI 151a,217,218, ) ) STEMI PCI PCI 3 PCI PCI STEMI STEMI primary PCI 24 primary PCI PCI STEMI primary PCI 242,243) STEMI 244,245) 28

29 ST ) primary PCI no reflow ) TIMI 253) 254,255) no reflow STEMI a) ,247,248) 12 STEMI primary PCI 12 ST primary PCI 29

30 2012 PCI facilitated PCI rescue PCI facilitated PCI PCI PCI PCI rescue PCI PCI STEMI 2 PCI PCI PCI PCI systematic PCI systematic PCI 83,84) systematic PCI primary PCI 256,257) PCI PCI 83,84) PCI CABG STEMI CABG ,259) CABG CABG 258, ) 267) STEMI CABG 48 CABG 266,268) CABG primary PCI CABG 30

31 ST 2013 CABG CABG 151a, ) CABG CABG 272) ST 273) CK CK-MB MB ) rescue PCI 275) primary PCI TIMI PCI TIMI 2 TIMI 3 276) TIMI frame count 277) TIMI 3 no reflow 1/4 278) myocardial blush grade blush 279,280) 281) primary PCI ST reperfusion arrhythmiast myocardial stunning 282) 283) 284) remote ischemic conditioning 285) 31

32 ) 294, 295) STEMI PCI primary PCI ACC/ AHA /kg ACT ) 286) ACT APTT 287,288) 6 3 HIT 289) 10 HIT I II I II PF4HIT STEMI 296) HIT PCI 297) HIT 2011 HIT PCI PCI 0.1 mg/kg g/kg/ 10 ACT 4 ACT ) 4 0.7g/kg/ APTT APTT g/kg/ 10 Xa OASIS- 5 Fifth Organization to Assess Strategies in Ischemic Syndromes ST ST PCI 299) 32

33 ST 2013 OASIS-6 STEMI 300) primary PCI 175) III Xa Xa STEMI 301) 172,176, ) 2012 J-AMI STEMI 300 mg/ 75 mg/ 304) STEMI 172,176,302,304,305) 600 mg ACC/AHA mg ) ACC/AHA STEMI ACC/AHA 1 85) j-cypher ) ) 12 2 dual anti-platelet therapy DAPT proton pump inhibitorppi 311,312) PPI PPI ) PPI PPI ) PPI H2 319) DAPT III primary PCI 320) 321) 33

34 2012 A reperfusion injury salvage kinase 0.025g/kg/ 3 HayashiKasama ST 322,323) J-WIND-ANP 569 PCI 0.025g/kg/ 3 CK ) ATP KATP KATP NO PCI Ito PCI 4 mg 24 6 mg/ no reflow 325) Ishii primary PCI mg TIMI frame count ST resolution 326) Iwakura 327) PCI TIMI 3 no reflow 328) 329) 2 mg 30 J-WIND-KATP 0.067mg/kg g/kg/ CK 324) AMISTAD 330) 331) primary PCI 332,333) EPO-AMI 34

35 ST 2013 II 334) STEMI PCI 282,335) 336) 337) STEMI 624 PCI 2 338,339) PCI 338,340) 273,341) 342) 340) ST PCI TIMI 0 343) primary PCI 344) primary VF 345) STEMI mg/ dl ) mg/dl ) Cigarroa 5 mlkg300 ml/ mg/dl 348) Gurm /Cockcroft-Gault 349) ) risk-benefit IABP 351,352) 35

36 ) N- 356) 357) 358) PCI ) 362) 363) 364) ) STEMI CCU CCU 1962 Day 365 Kansas Bethany Philadelphia Presbyterian Toronto 1968 coronary care unit CCU cardiac care unit circulatory care unit CCU chest pain unit chest pain center 366,367) CCU 368) CCU PCI CABG 300 CCU 369) CCU 370) Swan- Ganz 371) 372,373) CCU 36

37 ST 2013 CCU 369) Swan-Ganz pulmonary capillary wedge pressure: PCWP cardiac indexci 48 CK ,374,375) CCU PCI 1 376) PCI 6 79) 377) VII. 67 CCU 2 CK 2 PCI 800 kcal/ 6 g/ 378) 1 CCU ) 381) 382) 200 mg/dl 383,384) 385) CCU 386) Foley 387) 388) 37

38 ) 390) A CCU CCU 391) 3 PCI 396) no reflowpci CCU :. Killip 145) CKD T I brain natriuretic peptidebnp N NTproBNPST STEMI 392,393) primary PCI 394,395) STEMI primary PCI 20 STEMI STEMI primary PCI STEMI REACH 397) primary PCI 38

39 ST 2013 STEMI ,398) 2448 ACE ) mg/ STEMI 171,293,400) 75 mg/ 300 mg/ 171) STEMI PCI PCI 300 mg 75 mg/ 302) ) ACC/AHA 12 39

40 ,303,304) ,305) 401) DAPT2 402) PT-INR 2.0 LDL ) MUSASHI- AMI 406) LDL IVUS ESTABLISH 407) JAPAN-ACS 408) Extended- ESTABLISH 409) LDL LDL 410,411) Ca STEMI Ca 412,413) 414) 415) 416) 198 mg/dl DIGAMI 40

41 ST mg/dl mg/dl 417) 162 mg/dl GIK CREATE-ECLA 24 GIK 155 mg/dl 135 mg/dl 418) ) NICE-SUGER mg/dl180 mg/ dl 144 mg/dl 383) 40 mg/dl p p = ) 41

42 2012 VF VFprimary VF ) ) VF VF secondary VF VF PCI ICUCCU VF VF VF VF ISIS-3 345) III 428) VF 429) VF 162) ISIS-4 4 VF VF VT 1 2 cardiopulmonary resuscitationcpr AHA ACLS ) J J CPRVFVT 2 CPR 1mg CPR3 CPR AHA ) 300 mg 5 mg/kg QT torsades de pointes K VF VT 431,432) VF VF VT 433,434) 42

43 ST ,436) VF VT CPR VF VT VF VT CPR CPR percutaneous cardiopulmonary support systempcps CPR percutaneous cardiopulmonary support system PCPS PCI 437) STEMI VF VT intra-aortic balloon pumpingiabpextracorporeal membrane oxygenationecmo PCI 43

44 2012 VT 30 VT 30 VT VT VT 170bpm VT VT 438,439) wide-qrs tachycardia 12 wide-qrs tachycardia VT wide-qrs tachycardia VT VT VT VF VT 100J VT 430,440) VT AHA ) 2 VT 125 mg mg mg mg 24 VT VF 125 mg mg/24 VT ) VT VT 44

45 ST 2013 VT 431,432,445) mg/kg mg/kg/ torsades de pointes mg/kg mg/kg/ STEMI VT VF electrical storm ) IABP PCl 449,450) VT 451) VT VF ph CAST Ic 452) STEMI Ic AIVR 12 VF 344,453) AIVR VF ) 45

46 2012 STEMI ,455) ) 454) 456) 200 J J 430) Ca 457) 458) 459) 2008 ESC 121) 2011 ACCF/ AHA/HRS 460) 2 10 mg 1 1 mg mg/kg mg/kg/ 10.1mL/ kg 1 mg/kg mmhg 50/ 461) 462) Ca 60 6 ACE 455) CAPRICORN ) VF PEA 464) 465,466) 467) PEA ) PEA STEMI Ca 46

47 ST mg 5 3 mg 210g/ 210 g/kg/ 469). STEMI 614 STEMI 469). 470) 3 QRS 210g/ 210g/ kg/ 3 STEMI Mobitz II 2 STEMI 2 1 Mobitz I 2 STEMI ). STEMI 47

48 2012 His- Purkinje STEMI 1 474) ) 1 476) STEMI ) 1 extension Killip 102,478) STEMI 29,145,155,479) Swan-Ganz 480) Forrester 200 PCWPCI 4 hemodynamic subset 481) 48

49 ST 2013 ACE ARB IABP PCPS Nohria Nohria-Stevenson 482,483) Forrester 4 X 484) Swan-Ganz Swan-Ganz 5 485) 49

50 2012 primary PCI 486,487) noninvasive positive pressure ventilationnppv ) pressure support ventilation : PSV positive end expiratory pressurepeep bilevel positive airway pressure : BiPAP continuous positive airway pressurecpap 491) 492) 35 mg 493) mmhg 20 mg V2 494) A ANP ) PCI PAMI-II PCI IABP 498) PCI 3 IABP 50

51 ST ) 15g/kg/ IABP PCI CABG 500) 90mmHg30mmHg 20mL/ STEMI ) 30 X 502) Swan-Ganz 515g/kg/ 215g/kg/ g/kg/ IABP 503) PCPS 504,505). 2g/kg/ 2g/kg/ 5g/kg/ 1 2g/kg/ PDE- III STEMI ) PCI CABG SHOCK p ,151a) ESC IABP 2 51

52 ) multiple organ failuremof systemic inflammatory response syndromesirs IAPB 507,508) ESC IABP Impella 509) 510) ACE 49 STEMI ,512) V4R 1mm ST Kussmaul 511) 513,514) Swan-Ganz 10mmHg PCWP 5mmHg y noncompliant PCWP 15mmHg PCWP 18mmHg ml IABP 515) 516,517) CABG 52

53 ST ) STEMI 369,518a) STEMI 1 518b) Swan-Ganz IABP STEMI SHOCK Registry ) STEMI 1 53

54 b) GUSTO-I 520,521) 35 GUSTO-I SHOCK Registry ,522) ) 40 Doppler Swan-Ganz STEMI , ) ST-T PEA Q ,530) ,531) 525,526) STEMI ) PCI 54

55 ST CABG IABP 533,534) 521, ) Daggett 543) infarct-exclusion 544) 545,546) 547) blow-out mmHg 548) IABPPCPS ) 552) oozing sutureless 553) 55

56 ,555) 556,557) IABP STEMI IABP PCPS 1 left ventricular assist devicelvad PCPS STEMI ImpellaIABP 509) STEMI CK-MB MBH-FABP ST ST T pseudo-normalization 558) 7 PCI ,29) ,524) 20 primary PCI 6 181,241) 559) 56

57 ST ,524,560) primary PCI PCI CABG 561,562) STEMI 563,564) STEMI ST ) STEMI 565) Q oozing rupture 528) STEMI 1 T T T 566) CK-MB Doressler 567) g g 568) 569,570) 57

58 2012 STEMI ,571,572) STEMI STEMI ) STEMI 561,573,574) 573,575) SAVE 574) Killip IIIIV 576) 577,578) STEMI ) STEMI MRIMRA CT 579) STEMI 580) PCI 75 mg/ mg/ 581) PT-INR 2 STEMI ,582) distal protection device 583,584) ) p ) 587) PT-INR ,589) 590) 58

59 ST ,589) STEMI 588) 586) STEMI risk area avr ST V ) ST ST ST ST QRS avr ST 1mm ST 2.5mm0.25mV V1 ST V4V6 septal Q Seg.6 591) V5V6 2mm ST 592,593) III ST II I avl ST 594,595) IaVL ST avl II ST III V1V3 ST IaVL ST 596,597) Seg.4AV 12 V3RV6RV7V9 598) V4R 1mm ST V4RST ) V4 V7 V8 V9 ST Q 599,600) 600) Q ST T 4 V7V9 ST 601) 12 1mm ST T Q 1 601) 59

60 2012 STEMI ST ST resolution ST resolution ST 602,603) ST resolution ST ST resolution 604) Q Q MRI Q 605) T 24 T Q T T Q T 606) Q Q R R 607) R Q 12 R Q R Q QRS 608) QRS CK CK-MB I T ) T ,614) I T ) 10 STEMI 139,140) 615) WPW ASE ) normokinesis 1 hypokinesis2 akinesis3 60

61 ST 2013 dyskinesis4 aneurysm ) CK ) 621) 622) ) IX STEMI 624) 201 Tl 625,626) 99m Tc sestamibi MIBI 99m Tc tetrofosmin 99m Tc ) 631) 17 Berman ) 5 uptake uptake50 99m Tc MIBI Tl 633) 634) 99m Tc quantitative gated SPECTQGS QGS 635) 123 I-BMIPP SPECT 636,637) 201 Tl 123 I-BMIPP 638,639) 123 I-BMIPP SPECT risk area 99m Tc pyrophosphate CK 640) 641) ) MRIcardiac MRI:CMR MRIT2 MRI late gadolinium MRI: LGE-MRI MRI ) ) thickeningradial shortening 2005 MRI reference standard 648) CMR 61

62 2012 T2 LGE-MRI CMR LGE-MRI MRI ) 652) CT single photon emission computed tomographyspect SPECT MRI SPECT CMR SPECT CMR SPECT 649) ) ,655) CMR 656) LGE-MRI 10 LGE-MRI 657,658) 659) LGE-MRI positron emission tomographypet 660) LGE-MRI 661) PCI CABG 1 LGE-MRI ) 663) 664,665) 666) LGE-MRI 667) PCI 2050 slow flowno flow MRI microvascular obstruction MO CMR perfusion MRI LGE- MRI MO perfusion MRI 12 early MO 668) MO LGE-MRI 1015 late MO persistent MO 668) MO T2 T2 669,670) ,672) 673) 62

63 ST 2013 STEMI ) STEMI 674) PCI CABG PCI ) ) 3 SYNTAX ) 4 CABG 3.3 PCI ) 3 PCI CABG CABG 48 CABG 266,268) 2 primary PCI PCI PCI CABG PCI primary PCI staged PCI 679) PCI ) STEMI 48 63

64 ,268) CABG 677,680,681) 682,683) 684) CABG 685) STEMI 5 686) 2013 ACCF/AHA 24 CABG 175) STEMI 29,414,687,688) STEMI ) 692) ST 687, ) 1mm ST 64

65 ST ) 697,698) wall motion score index 698,699) Doppler ) ) 709) STEMI ) ) 715). 716). 717,718) 719) 99m TC 201 Tl 201 Tl 99m Tc 720) 201 Tl SPECT 625,626) ) ATP 723,727) 201 Tl 50 uptake stunned myocardium 123 I-BMIPP 636,728,729) STEMI 123 I-BMIPP 637) MRI 654,662,730) 668,673,731) PET 65

66 2012 PETSPECT 732,733). STEMI 688,734) 735,736) 737,738) 19,739) ) STEMI BNP 744) STEMI 745,746). BNP probnp N NT-proBNP 747) 1 748) BNP NT-proBNP 34 BNP 5 746) CRPC H-FABP ) STEMI 754) STEMI STEMI implantable cardioverter defibrillatoricd 755,756) 757) 66

67 ST 2013 ICD ) 758) ) QRS 762,763) T 764) ICD ) PCI STEMI 768,769) GRACE 152,153) TIMI 155) CADILLAC 157) STEMI ) 3 I phase I II phase II III phase III 3 STEMI QOL ) Taylor p p ) 1995 Lawler ) Haykowsky ) ACC/AHA ) ) STEMI AHA/ACCF ) 67

68 2012 STEMI QOL ) ) STEMI ) ) ) 9 21 PCI 770,772,780,789) 790,791) 2001 AHA 789) 2 STEMI ST T ST 9 68

69 ST ) ) Valsalva 369) STEMI 793) ) 6 780,789) STEMI 69

70 ) 2 STEMI 1 13 STEMI 787) 780,789) STEMI 70

71 ST ,795) STEMI 795) 3 796) ACC/AHA 795) ) Borg ,789) ,789,795) 798) STEMI 799) QOL 800) 801) ACC/AHA ) STEMI ) 71

72 2012 STEMI ) PCI PCI 612 PCI 802,803) ) 369,789,794) STEMI ACC/AHA ) ) ) 5METs 3METs3.06.0METs 6.1METs METs 6.1METs 3METs 6.1METs 805) 1 369) 72

73 ST ) AED 806) ) 5 5METs 807) ) 807) ) Q ) PCI 369) 811) PAMI-II PCI 2 812) STEMI ) QOL 369) STEMI 814) 369) SSRI 815,816) 1 STEMI STEMI ) social isolation 817) 818) 819) 820) STEMI 821) 822) QOL 818) 73

74 ) ) ) 74

75 ST

76 2012 *repetition maximum10 RM QOL ) AHA/ACCF ) VII

77 ST ) primary PCI 80 29,220,396) mg/ 176,302) DES PCI DAPT ) ACC/AHA/SCAI 832) FDA 833) DES 12 j-cypher ) ) ) 1 DAPT 830,831) DES PPI CYP2C19 313,317,835) PPI CYP2C19 836) 77

78

79 ST ) ) PCI ) ) 79

80 2012 ACC AHA ) ACC/AHA quality improvement : QI 842,844,845) 843) ACC/AHA STEMI 843) 1 ACC/ AHA 369,846) primary PCI STEMI ) ACCF/ AHA/SCAI PCI 400 PCI primary PCI PCI primary PCI 11 STEMI 308) CVIT 850) PCI J-PCI /National Clinical Database 851) 80

81 ST 2013 CCU CCU 6 58) 14 60,61) 181) ) ) STEMI AHA emergency cardiovascular care ECC CCU PCI STEMI 81

82 2012 ILCOR CoSTR 2005 AHA PCI 854) ) 3 STEMI CPR AED PADpublic access defibrillation 3 CCU PCI 2007 ACC/AHA 2008 ESC door-to-balloondtb 90 DTB Get With The Guidelines GWTG 2000 ACC/AHA 858,859) STEMI Community Education

83 83 ST 2013

84

85 85 ST 2013

86 Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Circulation 2012; 126: Davies MJ, Thomas AC. Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J 1985; 53: Fuster V, Badimon L, Badimon JJ, et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med 1992; 326: Rentrop KP, Blanke H, Karsch KR, et al. Acute myocardial infarction: intracoronary application of nitroglycerin and streptokinase. Clin Cardiol 1979; 2: DeWood MA, Spores J, Notske R, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980; 303: Kodama K, Asakura M, Ueda Y, et al. The role of plaque rupture in the development of acute coronary syndrome evaluated by the coronary angioscope. Intern Med 2000; 39: Asakura M, Ueda Y, Yamaguchi O, et al. Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction: an angioscopic study. J Am Coll Cardiol 2001; 37: Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995; 91: Schaar JA, Muller JE, Falk E, et al. Terminology for high-risk and vulnerable coronary artery plaques. Report of a meeting on the vulnerable plaque, June 17 and 18, 2003, Santorini, Greece. Eur Heart J 2004; 25: Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: ; 54: Yamagishi M, Terashima M, Awano K, et al. Morphology of vulnerable coronary plaque: insights from follow-up of patients examined by intravascular ultrasound before an acute coronary syndrome. J Am Coll Cardiol 2000; 35: Ueda Y, Ohtani T, Shimizu M, et al. Color of culprit lesion at 6 months after plain old balloon angioplasty versus stenting in patients with acute myocardial infarction. Am Heart J 2004; 148: Ino Y, Kubo T, Tanaka A, et al. Difference of culprit lesion morphologies between ST-segment elevation myocardial infarction and non-st-segment elevation acute coronary syndrome: an optical coherence tomography study. JACC Cardiovasc Interv 2011; 4: Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 2003; 108: van der Wal AC, Becker AE, van der Loos CM, et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994; 89: Okumura K, Yasue H, Matsuyama K, et al. Effect of acetylcholine on the highly stenotic coronary artery: difference between the constrictor response of the infarct-related coronary artery and that of the noninfarct-related artery. J Am Coll Cardiol 1992; 19: Forrester JS, Wyatt HL, Da Luz PL, et al. Functional significance of regional ischemic contraction abnormalities. Circulation 1976; 54: White HD, Norris RM, Brown MA, et al. Left ventricular endsystolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987; 76: Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990; 81: Pfeffer MA, Lamas GA, Vaughan DE, et al. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med 1988; 319: Ceremuzynski L. Hormonal and metabolic reactions evoked by acute myocardial infarction. Circ Res 1981; 48: Cheitlin MD, McAllister HA, de Castro CM. Myocardial infarction without atherosclerosis. JAMA 1975; 231: Pristipino C, Beltrame JF, Finocchiaro ML, et al. Major racial differences in coronary constrictor response between japanese and caucasians with recent myocardial infarction. Circulation 2000; 101: Bertrand ME, LaBlanche JM, Tilmant PY, et al. Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography. Circulation 1982; 65: Wu AH, Parsons L, Every NR, et al. Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2). J Am Coll Cardiol 2002; 40: Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: Kinjo K, Sato H, Ohnishi Y, et al. Prognostic significance of atrial fibrillation/atrial flutter in patients with acute myocardial infarction treated with percutaneous coronary intervention. Am J Cardiol 2003; 92: Kasanuki H, Honda T, Haze K, et al. A large-scale prospective cohort study on the current status of therapeutic modalities for acute myocardial infarction in Japan: rationale and initial results of the HIJAMI Registry. Am Heart J 2005; 150: Nakamura Y, Yamamoto T, Okamura T, et al. Combined cardiovascular risk factors and outcome: NIPPON DATA80, Circ J 2006; 70: Iso H, Sato S, Kitamura A, et al. Metabolic syndrome and the risk of ischemic heart disease and stroke among Japanese men and women. Stroke 2007; 38: Okayama A, Kadowaki T, Okamura T, et al. Age-specific effects of systolic and diastolic blood pressures on mortality due to cardiovascular diseases among Japanese men (NIPPON DATA80). J Hypertens 2006; 24: Fujishima M, Kiyohara Y, Kato I, et al. Diabetes and cardiovascular disease in a prospective population survey in Japan: The Hisayama Study. Diabetes 1996; 45 Suppl 3: S Tominaga M, Eguchi H, Manaka H, et al. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care 1999; 22: Takara A, Ogawa H, Endoh Y, et al. Long-term prognosis of diabetic patients with acute myocardial infarction in the era of acute revascularization. Cardiovasc Diabetol 2010; 9: Nishimura T, Nakajima K, Kusuoka H, et al. Prognostic study of risk stratification among Japanese patients with ischemic heart disease using gated myocardial perfusion SPECT: J-ACCESS study. Eur J Nucl Med Mol Imaging 2008; 35: Baba S, Iso H, Mannami T, et al. Cigarette smoking and risk of coronary heart disease incidence among middle-aged Japanese men and women: the JPHC Study Cohort I. Eur J Cardiovasc Prev Rehabil 2006; 13: Iso H, Date C, Yamamoto A, et al. Smoking cessation and mortality from cardiovascular disease among Japanese men and women: the JACC Study. Am J Epidemiol 2005; 161: Kawano H, Soejima H, Kojima S, et al. Investigators JACSSJ. Sex differences of risk factors for acute myocardial infarction in Japanese patients. Circ J 2006; 70: Okamura T, Kadowaki T, Hayakawa T, et al. What cause of mortality can we predict by cholesterol screening in the Japanese general population? J Intern Med 2003; 253: Imamura T, Doi Y, Arima H, et al. LDL cholesterol and the development of stroke subtypes and coronary heart disease in a general Japanese population: the Hisayama study. Stroke 2009; 40: Lloyd-Jones DM, Nam BH, DAgostino RB, et al. Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring. JAMA 2004; 291: Matsuzaki M, Kita T, Mabuchi H, et al. Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia. Circ J 2002; 66: Furukawa Y, Ehara N, Taniguchi R, et al. Coronary risk factor profile and prognostic factors for young Japanese patients undergoing coronary revascularization. Circ J 2009; 73:

87 ST National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: Gami AS, Witt BJ, Howard DE, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007; 49: Robertson TL, Kato H, Rhoads GG, et al. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California. Incidence of myocardial infarction and death from coronary heart disease. Am J Cardiol 1977; 39: Iso H, Kobayashi M, Ishihara J, et al. Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort I. Circulation 2006; 113: Yamagishi K, Iso H, Date C, et al. Fish, omega-3 polyunsaturated fatty acids, and mortality from cardiovascular diseases in a nationwide community-based cohort of Japanese men and women the JACC (Japan Collaborative Cohort Study for Evaluation of Cancer Risk) Study. J Am Coll Cardiol 2008; 52: Kokubo Y, Iso H, Ishihara J, et al. Association of dietary intake of soy, beans, and isoflavones with risk of cerebral and myocardial infarctions in Japanese populations: the Japan Public Health Centerbased (JPHC) study cohort I. Circulation 2007; 116: Noda H, Iso H, Toyoshima H, et al. Walking and sports participation and mortality from coronary heart disease and stroke. J Am Coll Cardiol 2005; 46: Rumana N, Kita Y, Turin TC, et al. Trend of increase in the incidence of acute myocardial infarction in a Japanese population: Takashima AMI Registry, Am J Epidemiol 2008; 167: Tanabe N, Saito R, Sato T, et al. Event rates of acute myocardial infarction and coronary deaths in Niigata and Nagaoka cities in Japan. Circ J 2003; 67: Sekikawa A, Ueshima H, Kadowaki T, et al. Less subclinical atherosclerosis in Japanese men in Japan than in White men in the United States in the post-world War II birth cohort. Am J Epidemiol 2007; 165: Yeh RW, Sidney S, Chandra M, et al. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med 2010; 362: Takii T, Yasuda S, Takahashi J, et al. Trends in acute myocardial infarction incidence and mortality over 30 years in Japan: report from the MIYAGI-AMI Registry Study. Circ J 2010; 74: CCU ICUCCU 2011; 35: CCUCCU 2003ICU CCU 2005; 29: ; 93: SOS-KANTO Committee. Incidence of ventricular fibrillation in patients with out-of-hospital cardiac arrest in Japan. Survivors after out-of-hospital cardiac arrest in Kanto Area (SOS-KANTO). Circ J 2005; 69: American Heart Association (AHA) in collaboration with International Liaison Committee on Resuscitation (ILCOR): Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care, An international consensus of science. Circulation 2000; 102: I Brodie BR, Gersh BJ, Stuckey T, et al. When is door-to-balloon time critical? Analysis from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) and CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trials. J Am Coll Cardiol 2010; 56: Shiomi H, Nakagawa Y, Morimoto T, et al; CREDO-Kyoto AMI investigators. Association of onset to balloon and door to balloon time with long term clinical outcome in patients with ST elevation acute myocardial infarction having primary percutaneous coronary intervention: observational study. BMJ 2012; 344: e CCU Ther Res 1997; 18: Hedges JR, Feldman HA, Bittner V, et al. Impact of community intervention to reduce patient delay time on use of reperfusion therapy for acute myocardial infarction: rapid early action for coronary treatment (REACT) trial. REACT Study Group. Acad Emerg Med 2000; 7: Canto JG, Zalenski RJ, Ornato JP, et al. National Registry of Myocardial Infarction 2 Investigators. Use of emergency medical services in acute myocardial infarction and subsequent quality of care: observations from the National Registry of Myocardial Infarction 2. Circulation 2002; 106: Goldberg R, Goff D, Cooper L, et al. Age and sex differences in presentation of symptoms among patients with acute coronary disease: the REACT Trial. Rapid Early Action for Coronary Treatment. Coron Artery Dis 2000; 11: Kitamura T, Iwami T, Kawamura T, et al. Implementation Working Group for the All-Japan Utstein Registry of the Fire and Disaster Management Agency. Nationwide public-access defibrillation in Japan. N Engl J Med 2010; 362: Hutchings CB, Mann NC, Daya M, et al. Rapid Early Action for Coronary Treatment Study. Patients with chest pain calling or self-transporting to reach definitive care: which mode is quicker? Am Heart J 2004; 147: SOS-KANTO study group. Cardiopulmonary resuscitation by bystanders with chest compression only (SOS-KANTO): an observational study. Lancet 2007; 369: De Luca G, Suryapranata H, Ottervanger JP, et al. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation 2004; 109: http:// go.jp/neuter/topics/houdou/2312/231216_1houdou/02_1.pdf : Fibrinolytic Therapy Trialists(FTT) Collaborative Group. Indication for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343: Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nellinfarto Miocardico (GISSI). Lancet 1986; 1: Armstrong PW, Collen D, Antman E. Fibrinolysis for acute myocardial infarction: the future is here and now. Circulation 2003; 107: Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 7: the era of reperfusion: section 1: acute coronary syndromes (acute myocardial infarction). The American Heart Association in collaboration with the International Liaison Committee on Resuscitation. Circulation 2000; 102: I OConnor RE, Brady W, Brooks SC, et al. Part 10: acute coronary syndromes: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010; 122: S Watanabe K, Nagao K, Watanabe I, et al. Relationship between the door-to-timi-3 flow time and the infarct size in patients suffering from acute myocardial infarction: analysis based on the fibrinolysis and subsequent transluminal (FAST-3) trial. Circ J 2004; 68: Nakao K, Sawamura T, Katayama N, et al. Facilitated PCI as a medical service sysytem in Japan. J Jpn Coron Assoc 2005; 11: Kimura K, Tsukahara K, Usui T, et al. Low-dose tissue plasminogen activator followed by planned rescue angioplasty reduces time to reperfusion for acute myocardial infarction treated at community hospitals. Jpn Circ J 2001; 65: Di Mario C, Dudek D, Piscione F, et al. Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial. Lancet 2008; 371: Cantor WJ, Fitchett D, Borgundvaag B, et al. TRANSFER-AMI Trial Investigators. Routine early angioplasty after fibrinolysis for acute myocardial infarction. N Engl J Med 2009; 360: Kushner FG, Hand M, Smith SC, et al Focused Updates: ACC/ AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice 87

88 2012 Guidelines. Circulation 2009; 120: Diercks DB, Kontos MC, Chen AY, et al. Utilization and impact of pre-hospital electrocardiograms for patients with acute ST-segment elevation myocardial infarction: data from the NCDR (National Cardiovascular Data Registry) ACTION (Acute Coronary Treatment and Intervention Outcomes Network) Registry. J Am Coll Cardiol 2009; 53: Scholz KH, Hilgers R, Ahlersmann D, et al. Contact-to-balloon time and door-to-balloon time after initiation of a formalized data feedback in patients with acute ST-elevation myocardial infarction. Am J Cardiol 2008; 101: ,. JRC EBM Hamm CW, Goldmann BU, Heeschen C, et al. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med 1997; 337: Ryan TJ, Anderson JL, Antman EM, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 1996; 28: Ryan TJ, Antman EM, Brooks NH, et al update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation 1999; 100: Herlitz J, Blohm M, Hartford M, et al. Delay time in suspected acute myocardial infarction and the importance of its modification. Clin Cardiol 1989; 12: Nallamothu BK, Bates ER. Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything? Am J Cardiol 2003; 92: Kannel WB. Prevalence and clinical aspects of unrecognized myocardial infarction and sudden unexpected death. Circulation 1987; 75: II Grimm RH, Tillinghast S, Daniels K, et al. Unrecognized myocardial infarction: experience in the Multiple Risk Factor Intervention Trial (MRFIT). Circulation 1987; 75: II Kosuge M, Kimura K, Ishikawa T, et al. Differences between men and women in terms of clinical features of ST-segment elevation acute myocardial infarction. Circ J 2006; 70: Patel H, Rosengren A, Ekman I. Symptoms in acute coronary syndromes: does sex make a difference? Am Heart J 2004; 148: Maynard C, Litwin PE, Martin JS, et al. Gender differences in the treatment and outcome of acute myocardial infarction. Results from the Myocardial Infarction Triage and Intervention Registry. Arch Intern Med 1992; 152: Weaver WD, Litwin PE, Martin JS, et al. Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction. The MITI Project Group. J Am Coll Cardiol 1991; 18: ; 41: Killip T, Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol 1967; 20: Timmis AD. Early diagnosis of acute myocardial infarction. BMJ 1990; 301: Tsukahara K, Kimura K, Kosuge M, et al. Clinical implications of intermediate QRS prolongation in the absence of bundle-branch block in patients with ST-segment-elevation acute myocardial infarction. Circ J 2005; 69: Hirano T, Tsuchiya K, Nishigaki K, et al. Clinical features of emergency electrocardiography in patients with acute myocardial infarction caused by left main trunk obstruction. Circ J 2006; 70: Hochrein J, Sun F, Pieper KS, et al. Higher T-wave amplitude associated with better prognosis in patients receiving thrombolytic therapy for acute myocardial infarction (a GUSTO-I substudy). Global Utilization of Streptokinase and Tissue plasminogen Activator for Occluded Coronary Arteries. Am J Cardiol 1998; 81: Braat SH, Brugada P, de Zwaan C, et al. Value of electrocardiogram in diagnosing right ventricular involvement in patients with an acute inferior wall myocardial infarction. Br Heart J 1983; 49: Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists(FTT) Collaborative Group. Lancet 1994; 343: Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia. Circulation 1994; 89: Rude RE, Poole WK, Muller JE, et al. Electrocardiographic and clinical criteria for recognition of acute myocardial infarction based on analysis of 3,697 patients. Am J Cardiol 1983; 52: Weaver WD, Eisenberg MS, Martin JS, et al. Myocardial Infarction Triage and Intervention Projectphase I: patient characteristics and feasibility of prehospital initiation of thrombolytic therapy. J Am Coll Cardiol 1990; 15: Karlson BW, Herlitz J, Wiklund O, et al. Early prediction of acute myocardial infarction from clinical history, examination and electrocardiogram in the emergency room. Am J Cardiol 1991; 68: Fisch C. The clinical electrocardiogram: sensitivity and specificity. ACC Curr J Rev 1997; 6: Wang K, Asinger RW, Marriott HJ. ST-segment elevation in conditions other than acute myocardial infarction. N Engl J Med 2003; 349: Sgarbossa EB, Pinski SL, Barbagelata A, et al. Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle-branch block. GUSTO-1 (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries) Investigators. N Engl J Med 1996; 334: ; 7: Yamaji H, Iwasaki K, Kusachi S, et al. Prediction of acute left main coronary artery obstruction by 12-lead electrocardiography. ST segment elevation in lead avr with less ST segment elevation in lead V(1). J Am Coll Cardiol 2001; 38: Kligfield P, Gettes LS, Bailey JJ, et al. Recommendations for the standardization and interpretation of the electrocardiogram: part I: The electrocardiogram and its technology: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: endorsed by the International Society for Computerized Electrocardiology. Circulation 2007; 115: Kosuge M, Ebina T, Hibi K, et al. Simple and accurate electrocardiographic criteria to differentiate takotsubo cardiomyopathy from anterior acute myocardial infarction. J Am Coll Cardiol 2010; 55: Field JM, Hazinski MF, Sayre MR, et al. Part 1: executive summary: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010; 122: S Van de Werf F, Bax J, Betriu A, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2008; 29: Adams GL, Campbell PT, Adams JM, et al. Effectiveness of prehospital wireless transmission of electrocardiograms to a cardiologist via hand-held device for patients with acute myocardial infarction (from the Timely Intervention in Myocardial Emergency, NorthEast Experience [TIME-NE]). Am J Cardiol 2006; 98: Afolabi BA, Novaro GM, Pinski SL, et al. Use of the prehospital ECG improves door-to-balloon times in ST segment elevation myocardial infarction irrespective of time of day or day of week. Emerg Med J 2007; 24: Terkelsen CJ, Lassen JF, Norgaard BL, et al. Reduction of treatment delay in patients with ST-elevation myocardial infarction: impact of pre-hospital diagnosis and direct referral to primary 88

89 ST 2013 percutanous coronary intervention. Eur Heart J 2005; 26: Dhruva VN, Abdelhadi SI, Anis A, et al. ST-Segment Analysis Using Wireless Technology in Acute Myocardial Infarction (STAT-MI) trial. J Am Coll Cardiol 2007; 50: Sekulic M, Hassunizadeh B, McGraw S, et al. Feasibility of early emergency room notification to improve door-to-balloon times for patients with acute ST segment elevation myocardial infarction. Catheter Cardiovasc Interv 2005; 66: Kojima S, Sakamoto T, Ishihara M, et al. Japanese Acute Coronary Syndrome Study investigators. The white blood cell count is an independent predictor of no-reflow and mortality following acute myocardial infarction in the coronary interventional era. Ann Med 2004; 36: Wahab NN, Cowden EA, Pearce NJ, et al. ICONS Investigators. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol 2002; 40: Iwakura K, Ito H, Ikushima M, et al. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol 2003; 41: Kosuge M, Kimura K, Kojima S, et al; Japanese Acute Coronary Syndrome Study (JACSS) Investigators. Effects of glucose abnormalities on in-hospital outcome after coronary intervention for acute myocardial infarction. Circ J 2005; 69: Luepker RV, Apple FS, Christenson RH, et al. Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation 2003; 108: Katus HA, Remppis A, Looser S, et al. Enzyme linked immuno assay of cardiac troponin T for the detection of acute myocardial infarction in patients. J Mol Cell Cardiol 1989; 21: Ahumada G, Roberts R, Sobel BE. Evaluation of myocardial infarction with enzymatic indices. Prog Cardiovasc Dis 1976; 18: Lee TH, Goldman L. Serum enzyme assays in the diagnosis of acute myocardial infarction. Recommendations based on a quantitative analysis. Ann Intern Med 1986; 105: Halkin A, Stone GW, Grines CL, et al. Prognostic implications of creatine kinase elevation after primary percutaneous coronary intervention for acute myocardial infarction. J Am Coll Cardiol 2006; 47: Thygesen K, Alpert JS, White HD, et al. Universal definition of myocardial infarction. Circulation 2007; 116: Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Circulation 2012; 126: Tanaka K, Seino Y, Ohbayashi K, et al. Cardiac emergency triage and therapeutic decisions using whole blood rapid troponin T test for patients with suspicious acute coronary syndrome. Jpn Circ J 2001; 65: Reichlin T, Hochholzer W, Bassetti S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009; 361: Keller T, Zeller T, Peetz D, et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009; 361: Seino Y, Ogata K, Takano T, et al. Use of a whole blood rapid panel test for heart-type fatty acid-binding protein in patients with acute chest pain: comparison with rapid troponin T and myoglobin tests. Am J Med 2003; 115: Kontos MC, Arrowood JA, Paulsen WH, et al. Early echocardiography can predict cardiac events in emergency department patients with chest pain. Ann Emerg Med 1998; 31: Autore C, Agati L, Piccininno M, et al. Role of echocardiography in acute chest pain syndrome. Am J Cardiol 2000; 86: 41G-42G Lee KL, Woodlief LH, Topol EJ, et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators. Circulation 1995; 91: Mehilli J, Kastrati A, Dirschinger J, et al. Sex-based analysis of outcome in patients with acute myocardial infarction treated predominantly with percutaneous coronary intervention. JAMA 2002; 287: Kosuge M, Kimura K, Kojima S, et al. Japanese Acute Coronary Syndrome Study (JACSS) Investigators. Sex differences in early mortality of patients undergoing primary stenting for acute myocardial infarction. Circ J 2006; 70: Mehta RH, Oneill WW, Harjai KJ, et al. Primary Angioplasty in Myocardial Infarction (PAMI) and the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Investigators. Prediction of one-year mortality among 30-day survivors after primary percutaneous coronary interventions. Am J Cardiol 2006; 97: Jeger RV, Harkness SM, Ramanathan K, et al. Emergency revascularization in patients with cardiogenic shock on admission: a report from the SHOCK trial and registry. Eur Heart J 2006; 27: Hochman JS, Sleeper LA, White HD, et al; SHOCK Investigators. One-year survival following early revascularization for cardiogenic shock. JAMA 2001; 285: a. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med 1999; 341: b. Webb JG, Sleeper LA, Buller CE, et al. Implications of the timing of onset of cardiogenic shock after acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shock? J Am Coll Cardiol 2000; 36: Fox KA, Dabbous OH, Goldberg RJ, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ 2006; 333: Eagle KA, Lim MJ, Dabbous OH, et al. GRACE Investigators. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA 2004; 291: Nakatani D, Sakata Y, Suna S, et al. Impact of beta blockade therapy on long-term mortality after ST-segment elevation acute myocardial infarction in the percutaneous coronary intervention era. Am J Cardiol 2013; 111: Morrow DA, Antman EM, Charlesworth A, et al. TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous npa for treatment of infarcting myocardium early II trial substudy. Circulation 2000; 102: Morrow DA, Antman EM, Giugliano RP, et al. A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudy. Lancet 2001; 358: Halkin A, Singh M, Nikolsky E, et al. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. J Am Coll Cardiol 2005; 45: Maroko PR, Radvany P, Braunwald E, et al. Reduction of infarct size by oxygen inhalation following acute coronary occlusion. Circulation 1975; 52: Fillmore SJ, Shapiro M, Killip T. Arterial oxygen tension in acute myocardial infarction. Serial analysis of clinical state and blood gas changes. Am Heart J 1970; 79: Bussmann WD, Passek D, Seidel W, et al. Reduction of CK and CK-MB indexes of infarct size by intravenous nitroglycerin. Circulation 1981; 63: GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nellinfarto Miocardico. Lancet 1994; 343: ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. Lancet 1995; 345: Cheitlin MD, Hutter AM Jr, Brindis RG, et al. ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart Association.J Am Coll Cardiol 1999; 33: Every NR, Parsons LS, Hlatky M, et al. A comparison of thrombolytic therapy with primary coronary angioplasty for acute 89

GL_高野班_D.indd

GL_高野班_D.indd Circulation Journal Vol. 72, Suppl. IV, 2008 1443 PCI CCU STEMI CABG ST ST1 EBM ST ST ST ST ST ST 1 EBMEvidence-Based Medicine 1444 Circulation Journal Vol. 72, Suppl. IV, 2008 ACS ST T ST CLBBB ST ACS

More information

C/NC : committed/noncommitted

C/NC : committed/noncommitted C/NC : committed/noncommitted 110 time post-icd implant 1) The Cardiac Arrhythmia Suppression Trial (CAST) Investigators Preliminary report : Effect of encainaide and flecainide on mortality in a

More information

110木村班DG念校.indd

110木村班DG念校.indd 日本循環器学会日本冠疾患学会日本救急医学会日本胸部外科学会日本集中治療医学会 日本心血管インターベンション治療学会 日本心臓血管外科学会 日本心臓病学会 日本心臓リハビリテーション学会 日本心電学会 日本動脈硬化学会 木村一雄横浜市立大学附属市民総合医療センター心臓血管センター 浅井徹滋賀医科大学心臓血管外科 小川久雄熊本大学大学院生命科学研究部循環器内科学国立循環器病研究センター 奥村謙弘前大学医学部循環器内科

More information

_02.indd

_02.indd 30, 11-16, 2010 Z Z score Computed tomography ROC analysis 3 CT 1,2 CT 1/3 3 5 CT CT 6 7,8 MCA ASPECTS Alberta Stroke Programme Early CT Score 4 10 CT ASPECTS 50% 9 Z 10 CT Z CT 10 Z Z Z receiver operating

More information

本文.indd

本文.indd CQ ACC/AHA PECO PatientExposure Comparison OutcomePECO low-density lipoprotein cholesterol LDL C cholesterol cholesterol intensive OR agressive CQ target LDL C PubMed Systematic Reviews Clinical Study

More information

2001 2003 2005 2006 2007 2008

2001 2003 2005 2006 2007 2008 2001 2003 2005 2006 2007 2008 60 etc. http://nosmoke.hp.infoseek.co.jp/yuugaibussitu.htm http://nosmoke.hp.infoseek.co.jp/yuugaibussitu.htm 23.5% 2.8% 2.8% 3.4% 30.3% 9.9% 11.5% 15.8% AAN 65

More information

Journal Club 2017/05/30 Tomohiro Matsumoto PGY-2

Journal Club 2017/05/30 Tomohiro Matsumoto PGY-2 Journal Club 2017/05/30 Tomohiro Matsumoto PGY-2 本 の論 March 21, 2017 2 Introduc)on 3 : (CIN) 3 25% 44µmol/L(0.5mg/dL) CIN 4 European Society of Urogenital Radiology. ESUR guidelines on contrast media,

More information

HEART'S Original A case of Brugada syndrome with a high defibrillation threshold in which defibrillation was successful by Active Can off defibrillation Keisuke Kawachi, Yukei Higashi, Yuuki Honda, Kouhei

More information

35 40mmHg PaCO2 40mmHg 35mmHg CO2 PETCO2 CO2 CO2 10mmHg CPR CO2 10mmHg ROSC() CO mmHg ROSC return of spontaneous circulation ROSC 17mmHg ROSC 20

35 40mmHg PaCO2 40mmHg 35mmHg CO2 PETCO2 CO2 CO2 10mmHg CPR CO2 10mmHg ROSC() CO mmHg ROSC return of spontaneous circulation ROSC 17mmHg ROSC 20 2010 ACLS Circulation Nov.2,2010 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care p640-p767 2010BLS 2010ACLS BLS Circulation, Nov2.2010 2010

More information

”RŠœ15-3 #50 ‘¬’X 4“Z+

”RŠœ15-3 #50 ‘¬’X 4“Z+ 15 3 45 57 2000 QOL 1950 Cardiac Arrhythmia Suppression Trial 10 WPW 1 10 1990 1996 409-3898 1110 2000 5 23 2000 6 2 4 46 2 2 3 2 1 1 3 3 40 1 10 6 12 Cardiac Arrhythmia Suppression Trial CAST 4 1 3 CAST

More information

8 The Bulletin of Meiji University of Integrative Medicine API II 61 ASO X 11 7 X-4 6 X m 5 X-2 4 X 3 9 X 11 7 API 0.84 ASO X 1 1 MR-angio

8 The Bulletin of Meiji University of Integrative Medicine API II 61 ASO X 11 7 X-4 6 X m 5 X-2 4 X 3 9 X 11 7 API 0.84 ASO X 1 1 MR-angio 7-14 2010 1 1 1 2 1 1 1 2 Fontaine II ASO61 3 API ASO ASO ASO API API KKKKKKKKKK ASO Fontaine II API Received April 14, 2009; Accepted July 16, 2009 I arteriosclerosis obliterans: ASO ASO 50 70 1,2 Fontaine

More information

Microsoft Word - 「黄砂とその健康影響について」小冊子180323版

Microsoft Word - 「黄砂とその健康影響について」小冊子180323版 ...1...1...1...2...4...4...4...6...7...7...7...7...8...8...9...9...10... 11... 11... 11... 11...12...12...13...16...18...20 1 1-1 1-2 1 1 km 24.5 m/s 10 50 m 1 1-3 μm 1-4 1-5 2 8 http://www.jma-net.go.jp/sat/himawari/obsimg/image_dust.html

More information

‹Àfi¡‚¾”O/…_…C…W…F…X…g/01-01

‹Àfi¡‚¾”O/…_…C…W…F…X…g/01-01 2002 2003 Guidelines for the Diagnosis,Treatment and Prevention of Pulmonary Thromboembolism and Deep Vein Thrombosis (JCS 2004) h 1 2 3 1 1 2 2-1 2-2 2-3 2-4 2-5 2-6 2 1 2 2-1 2-2 3 1 2 4 Circulation

More information

37, 9-14, 2017 : cefcapene piperacillin 3 CT Clostridium difficile CD vancomycin CD 7 Clostridium difficile CD CD associate

37, 9-14, 2017 : cefcapene piperacillin 3 CT Clostridium difficile CD vancomycin CD 7 Clostridium difficile CD CD associate 37, 9-14, 2017 : 36 2015 8 6 cefcapene piperacillin 3 CT Clostridium difficile CD vancomycin 20 1983 2016 3 CD 7 Clostridium difficile CD CD associated diarrhea : CDAD CD 1,2 PPI 3 1 36 33 2015 8 6 5 5

More information

Microsoft PowerPoint - LITA-noreflow_English.pptx

Microsoft PowerPoint - LITA-noreflow_English.pptx A case of no-reflow phenomenon during PCI to LIMA graft Iwatsuki-Minami hospital, Saitama, Japan Koichi Sano, Masaki Tsukagoshi, Yasunari Ueno, Seiichi Fukuda, Takayoshi Sato, Yasuyuki Maruyama 77 y.o.

More information

特殊病態下感染症における抗菌薬治験の手引き作成委員会報告書(案)

特殊病態下感染症における抗菌薬治験の手引き作成委員会報告書(案) VOL.51 NO.6 JUNE 2003 JUNE 2003 9) Niederman MS et al: Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy and prevention.

More information

核 WG.indd

核 WG.indd 15 平成 25 年度ワーキンググループ報告 25 3 MDCT SPECT FDG-PET γ 8 16 25 MDCT SPECT 6 MDCT SPECT Dual source CT SPECT 5 (rt-pa) MDCT SPECT 2 MDCT SPECT 7 rt-pa 95% rt-pa 8.1% 17% 1) 65 rt-pa 7 rt-pa 2 MDCT (submassive

More information

J Cardiol 2006 Dec; 48 6 : Clinical Report : Survey of Coronary Spasm in Japan Before the Establishment of Spasm Guideline: Analysis of Questi

J Cardiol 2006 Dec; 48 6 : Clinical Report : Survey of Coronary Spasm in Japan Before the Establishment of Spasm Guideline: Analysis of Questi Clinical Report : Survey of Coronary Spasm in Japan Before the Establishment of Spasm Guideline: Analysis of Questionnaires in All Japan Shozo Akira Yousuke Hiroaki Hiroshi SUEDA, MD,FJCC OSHITA, MD IZOE,

More information

untitled

untitled 72 22 30 1985 Conductance Vessels flow Vessels< - Shear stress conductance vessel Exercise and Adenosine SPECT in the Patient with Angina SPECT,PET ACC/AHA/ASNC Guideline 2003 Dicarli JNM 2007;48:783

More information

JCAS 対象および方法 prospective registry CEA CAS JCAS RCT 2 JCAS TIA minor stroke major stroke mrs CEA CAS 1 3 SPECT case volume CEA CAS 結果

JCAS 対象および方法 prospective registry CEA CAS JCAS RCT 2 JCAS TIA minor stroke major stroke mrs CEA CAS 1 3 SPECT case volume CEA CAS 結果 Online publication January 14, 2011 原 著 第 50 回総会シンポジウム 5 日本脳神経血管内治療学会 : 頭頸部 頭蓋内血管に対する血行再建術 本邦における頸動脈治療の前向き登録 (JCAS 研究 ) 1 1 JCAS 要旨 :JCAS 5053 1164 69.8 87 45 CAE 34 CAS 2130 major adverse events CEA 3.2

More information

1315 (15)

1315 (15) (14) 1315 (15) 1316 (16) 1317 (17) 1318 (18) 1319 (19) 1320 (20) 1321 (21) 1322 quinidine, disopyramide, and procainamide in isolated atrial myocytes : Mediation by 2) Inoue H, et al: Effects of pentisomide

More information

untitled

untitled 5 K 5 3 HP http://www.mhlw.go.jp/bunya/shakaihosho/iryouseido01/taikou03.html 2004 1 2 1 http://www.dm-net.co.jp/calendar/2007/06/005835.php 6 85cm 100cm 2 90cm 2 TG 150mg/dl HDLHDL-C 40mg/dl 130mmHg 85mmHg

More information

PTCA CABG 2PTCA & CABG 3 4 PTCA CABG 1 2 3PTCA & CABG 4 5 PTCA CABG follow-up Japanese Circulation Journal Vol. 64, Suppl. IV, 2000

PTCA CABG 2PTCA & CABG 3 4 PTCA CABG 1 2 3PTCA & CABG 4 5 PTCA CABG follow-up Japanese Circulation Journal Vol. 64, Suppl. IV, 2000 19981999 JR PTCACABG 1 2 PTCA 3 PTCA 4 OP-CABG MID-CAB PTCACABG 1 PTCA PTCA CABG 2 1 PTCA PTCA PTCA PTCA PTCA 2CABG CABG CABG CABG 3PTCA CABG Japanese Circulation Journal Vol. 64, Suppl. IV, 2000 1009

More information

GL_高野班.indd

GL_高野班.indd ACS Circulation Journal Vol. 72, Suppl. IV, 2008 1347 PCI CCU CCU STEMI CABG ST ST 1 EBM ST ST ST ST EBMEvidence-Based Medicine 1348 Circulation Journal Vol. 72, Suppl. IV, 2008 ACS ST T ST CLBBB ST ACS

More information

脈管学55巻11号 pp

脈管学55巻11号 pp Online publication December 10, 2015 191 原 著 55 21 1 2 2 1 2 2 2 2 1 要旨 : 8 21 19 2 4 1 20 SMA short segment J Jpn Coll Angiol 2015; 55: 191 196 Key words: superior mesenteric artery, dissection, conservative

More information

Single slice helical CT CT 1 2005 1 4 1. CT Anti-Lung Cancer Association: ALCA 1-5) 1993 9 10 ALCA (Nawa 6) ) single slice helical CT 10mm CT 2. 1 (http://www.thoracic-ctscreening.org/jpn/index.html )

More information

Response of pre-and postoperative Glucose- Insulin-Kalium (GIK) loading in patients with valve replacement. Isao Sakashita*, Takeshi Ando*, Tetsunosuk

Response of pre-and postoperative Glucose- Insulin-Kalium (GIK) loading in patients with valve replacement. Isao Sakashita*, Takeshi Ando*, Tetsunosuk Response of pre-and postoperative Glucose- Insulin-Kalium (GIK) loading in patients with valve replacement. Isao Sakashita*, Takeshi Ando*, Tetsunosuke Matsukawa* *Department and Ken-ichi Asano*. of Thoracic

More information

50-3ガイド10ポ.indd

50-3ガイド10ポ.indd 25 7 乳房専用 PET 診療ガイドライン作成メンバー PET 1 はじめに PET 18 F-2- -2- -D- FDG 14 12 FDG-PET FDG-PET 1) T1b 0.5 cm 1.0 cm T1c 1.0 cm 2.0 cm P=0.003 1.0 cm 2) MRI FDG-PET PET 1 cm FDG FDG 1 対向型乳房専用 PET 装置 2 2 3 6) 2 4

More information

老人性不整脈

老人性不整脈 資料 : QOL CHADS NOAC はじめに common disease 高齢者の不整脈の頻度, AF AVB RBBB LBBB Cardiovascular Health Study, 137 表 1 Outpatient Atarashi Cardiovascular Health Study Monolio No F M Ectopic beats Supraventricular.

More information

1) Delbet P: Retrocissement du choledoque. Cholecysto-duodenostomie. Bull Mem Soc Nat Chir 50: 1144-1146, 1924 2) Wiesner RH, LaRusso NF: Clinicopathologic Features of the Syndrome of Primary Sclerosing

More information

01

01 A registry study of Kawasaki disease patients with coronary artery aneurysms : : 183-8561 2-8-29 Tel. 042-300-5111 FAX. 042-312-8162 E-mail mmiura-pccs@umin.ac.jp : 1.02016630 2.02016925 3.02017831 1.

More information

1) Stallmann, F. W., and Pipberger, H. V.: Automatic recognition of electrocardiographic waves by digital computer. Circulation Research, 9, 1138, 1961. 2) Whitemen, J. R., Gorman, P. A., Calataynd, J.

More information

胆石症

胆石症 ,. vs 64 .. vs. -, Ransohoff DF, Gracie W. Treatment of gallstones. Ann Intern Med ; 119 : - Halldestam I, Enell EL, Kullman E, et al. Development of symptoms and complications in individuals with asymptomatic

More information

WHO Library Cataloguing in Publication Data 2003, Wilkinson,Richard Marmot,Michael Social determinants of health SDH The social gradient Stress Early life Social exclusion Work Unemployment Social support

More information

スライド 1

スライド 1 Wilhelm Conrad Röntgen Mr. and Mrs. Röntgen s hands (1895) X 1895 11 8 CT 0.6 500 CT NPO 0.8 /1 CT MDCT 4 1998 0.35 /1 8 16 64 2004 Takayasu CAD+PAD CT CT Angiography CTA SG Adamkiewicz PCI CABG CTA plaque

More information

審査報告書(案)

審査報告書(案) 19 83 7 18 628 1 19 8 3 7 18 6 28 30 MI 31 360 21700BZY00247000 5mm CEA 59 mm 2 50% 80 1. 2. 3 19 8 3 [ ] 7 [ ] [ ] [ ] [ ] 18 6 28 [ ] CEA 49mm 50 80 2 4 carotid endarterectomy CEA 1,2 CEA ECST 3 NASCET

More information

Fig. 1 Trends of TB incidence rates for all forms and smear-positive pulmonary TB in Kawasaki City and Japan. Incidence=newly notified cases of all fo

Fig. 1 Trends of TB incidence rates for all forms and smear-positive pulmonary TB in Kawasaki City and Japan. Incidence=newly notified cases of all fo Kekkaku Vol. 79, No. 1: 17-24, 2004 17 (Received 21 Aug. 2003/Accepted 18 Nov. 2003) Fig. 1 Trends of TB incidence rates for all forms and smear-positive pulmonary TB in Kawasaki City and Japan. Incidence=newly

More information

32 1 BRONJ BRONJ II BRONJ BRONJ 4 BP BRONJ 6 1 III BP BRONJ

32 1 BRONJ BRONJ II BRONJ BRONJ 4 BP BRONJ 6 1 III BP BRONJ 29 1 31 40 2014 31 Bisphosphonate related osteonecrosis of jaw; BRONJ 2008 4 2012 3 36 98 8 11 19 BRONJ 0 13 2 5 3 1 1 0 BP 4 15 10 5 α-streptococcus 0 BRONJ BRONJ BP I Paget 1 409-3898 1110 2014 1 27

More information

Editor Mary Fran Hazinski, RN, MSN Associate Editors Leon Chameides, MD Robin Hemphill, MD, MPH Ricardo A. Samson, MD Stephen M. Schexnayder, MD Eliza

Editor Mary Fran Hazinski, RN, MSN Associate Editors Leon Chameides, MD Robin Hemphill, MD, MPH Ricardo A. Samson, MD Stephen M. Schexnayder, MD Eliza アメリカ心臓協会 心肺蘇生と救急心血管治療のためのガイドライン 2010 2010 American Heart Association Guidelines for CPR and ECC の ハイライト 目次 全救助者に共通の主要な問題 1 市民救助者による成人への CPR 3 ヘルスケアプロバイダーによる BLS 5 電気的治療 9 心肺蘇生手技と器具 12 二次救命処置 13 急性冠症候群

More information

第61巻5・6号(12月号)/特集1頁目(本刷)

第61巻5・6号(12月号)/特集1頁目(本刷) Special Issue 1Sudden cardiac death symposium in Tokushima Special Issue 2How to do for your health? Reviews Original Epidemiologic problems of sudden death of school children in Tokushima Prefecture

More information

食道がん化学放射線療法後のsalvage手術

食道がん化学放射線療法後のsalvage手術 2006 2 17 52 Daly JM, et al. J Am Coll Surg 2000;190:562-573 Esophageal Cancer: Results of an American College of Surgeons Patient Care Evaluation Study Daly JM, et al. J Am Coll Surg 2000;190:562-573

More information

<93C195CA D834F E696E6464>

<93C195CA D834F E696E6464> 45 I I Diabetes and Heart: Insight by Imaging Juhani Knuuti Turku PET Centre, Turku University Central Hospital II I Development and Application of Beta-Amyloid Imaging Agents Chet A. Mathis Department

More information

mg 8 mg X Cr 9.84 mg/ dl K 1.5 meq/l CK 24,570 U/L Mb 79,530 ng/ml Mb 230,000 ng/ ml AKI 2 IHD IHD 4 IHD

mg 8 mg X Cr 9.84 mg/ dl K 1.5 meq/l CK 24,570 U/L Mb 79,530 ng/ml Mb 230,000 ng/ ml AKI 2 IHD IHD 4 IHD 31 1 15 20 2016 15 3 65 5 mg 8 mg 10 15 201X 7 1 11 15 Cr 9.84 mg/ dl K 1.5 meq/l CK 24,570 U/L Mb 79,530 ng/ml Mb 230,000 ng/ ml AKI 2 IHD IHD 4 IHD AKI HD 2004 48 Acute Kidney Injury AKI 48 Cr 0.3 mg/dl

More information

untitled

untitled gold standard CT gold standard 1960 1970 1980 1990 CABG ) New device 2000 DES Cumulative Survival rate 100 90 80 70 60 SVD DVD TVD 96.0 94.5 80.7 n=453 n=220 n=198 91.9 87.4 64.2 50 1 2 3 4 5 6 7 8 9

More information

Electrophysiologic and vectorcardiologic studies in a patient with Wolff-Parkinson-White syndrome Type A associated with complete right bundle branch block Yasuki Sakamoto*, Shunpei Ohkubo*, Shutaro Satake*,

More information

Influences of mortality from main causes of death on life expectancy. \ An observation for the past 25 years, 1950-1975, in Japan \ Takao SHIGEMATSU* and Zenji NANJO** With the Keyfitz-Nanjo method an

More information

JSACHD_Vol4_No2_Dec2015.book

JSACHD_Vol4_No2_Dec2015.book 4 2 30 35 (2015 ) cyanotic congenital heart disease, compensated erythrocytosis, iron replacement therapy ( 1) Hb = 57.5 (0.444 x ) 1) 1 2 30 (2015 12 ) SpO2 < 75% 2 (Ht) 2) Ht 3) QOL 4) MCV MCH TIBC Ht

More information

Coronary spasm associated myocardial infarction without organic stenosis at acute stage Yoshiaki Mikuriya*, Yoichi Tatsukawa*, Fumie Yufu*, Hirofumi Zaizen*, Katsuhiro Wakayama*, Yuuki Matsumoto*, Shoji

More information

−Û”RflÇ-…_…C…W…F…X…g-01

−Û”RflÇ-…_…C…W…F…X…g-01 2004-2005 Guidelines for Treatment of Acute Heart Failure (JCS 2006) h Y 2006 11 1 2 2-1 2-2 3 3-1 3-2 1 2 2-1 2-212 2-3 2-4 X 2-5 3ICUCCU 3-1 3-2 3-3 3-4 1 1-1 1-2 1-3 1-4 1-5 2 3 4 4-1 4-2 4-3 1 2004-2005

More information

静 脈 学 Table 1 Patient characteristics Symptom Case Age Sex Site PE Cause Treatment 1 44 M RSCV swelling (+) unknown UK, anticoaglant patent Result 2 5

静 脈 学 Table 1 Patient characteristics Symptom Case Age Sex Site PE Cause Treatment 1 44 M RSCV swelling (+) unknown UK, anticoaglant patent Result 2 5 Paget-Schroetter 3 Paget-Schroetter 3 1 1 1 3 86 42 Paget-Schroetter 2013 24 1 71- Paget-Schroetter 3 Table 1 1 44 1 CT 1 2012 4 19 CT CT Fig. 1 2 54 CT Fig. 2 71 静 脈 学 Table 1 Patient characteristics

More information

診療ガイドラインのカラクリ

診療ガイドラインのカラクリ EBM EBM 2-3 (evidence-based medicine: EBM) EBM 1 1 1 2 B burden belief bargain barrier A. JAMA EBMer JAMA EBM 3 EBM 3 EBM 3 3 B. peer review Field(IOM) Shaneyfelt ( Guidelines Qualities Assessment Questionnaire:

More information

14 00 14 50 3DO3-1 DO3-5 DO3-1 DO3-2 DO3-3 DO3-4 DO3-5 1 1 2 3 3 3 3 3 3 3 1.2. 3. 15 1 2 3 1. 2. 3. 1, 2 2, 3 1, 2 1. 2. JSEPTIC 3. ICU 1 2 1.2. 医 一

14 00 14 50 3DO3-1 DO3-5 DO3-1 DO3-2 DO3-3 DO3-4 DO3-5 1 1 2 3 3 3 3 3 3 3 1.2. 3. 15 1 2 3 1. 2. 3. 1, 2 2, 3 1, 2 1. 2. JSEPTIC 3. ICU 1 2 1.2. 医 一 第 1 日 目 第 1 日 目 (2 月 9 日 ) 一 演 題 医 師 部 門 演 第 6 会 場 ホテル 日 航 東 京 3F レインボーテラス 9 00 9 50 1 DO1-1 DO1-5 DO1-1 DO1-2 DO1-3 DO1-4 DO1-5 Presepsin LPS PGC-1 1 2 3 2 3 1 1. 2.3. Critical illness polyneuropathy

More information

JC46302

JC46302 1 Cardiac Rupture Caused by Myocardial Infarction in the Diagonal Branch Area: Evaluation by Cardiac Multislice Computed Tomography: A Case Report 1 1 2 2 Nobuaki Kentaro Ken Masatoshi Naoyuki Yoshito

More information

1_2.eps

1_2.eps 第32回 日本頭頸部癌学会ランチョンセミナー6 Pre-Meeting Abstract FDG-PET の頭頸部癌における臨床的有用性 司会 長 放射線治療センター長 講演 1 耳鼻咽喉科 部長 講演 2 PETセンター長 岡村 光英 先生 日時 2008年6月13日 金 12:00 13:00 会場 ハイアットリージェンシー東京 共催 第32回 日本頭頸部癌学会 日本メジフィジックス株式会社 136-0075

More information

2009年133巻3号3月号.indb

2009年133巻3号3月号.indb Folia Pharmacol. Jpn.133 1 2 Chiroscience UCB S RR-..% AA C IC C/A A/ A R- II/ III II/III Chiroscience UCB S 1 - E-mail: koji_taya@maruishi-pharm.co.jp Author: Koji Taya, Satoshi Shimizu Title: Levobupivacaine

More information

動くレントゲン

動くレントゲン FPD 1985 1998 2000 2002 FPD X X X FPD X CAD X FPD X CAD X X 1970 Autofluoroscope Toffolo RR, et al. The autofluoroscope and 133-Xe in dynamic studies of pulmonary perfusion and ventilation. Radiology,

More information

Table 1 Characteristics of the study participants in Imari municipal hospital

Table 1 Characteristics of the study participants in Imari municipal hospital Key words: tuberculosis, booster phenomenon, two-step tuberculin test Table 1 Characteristics of the study participants in Imari municipal hospital Fig. 1 Frequency distributions of size of the first tuberculin

More information

METs WPW QT LQTS 9Brugada 0 METs 30 Circulation Journal Vol. 67, Suppl. IV,

METs WPW QT LQTS 9Brugada 0 METs 30 Circulation Journal Vol. 67, Suppl. IV, 2002002 Guidelines for Exercise Eligibility at Schools, Work-Sites, and Sports in Patients with Heart Diseases (JCS 2003) JR 2 3 2 3 2 2 3 2 2 3 Circulation Journal Vol. 67, Suppl. IV, 2003 309 2002002

More information

_心臓49-2_討論会1-4.indd

_心臓49-2_討論会1-4.indd 心臓リモデリング 心不全 : 将来へのチャレンジ Heart Failure Registries in Japan ATTEND ₁ ₂₀% ₁ ₄₀% ₁ J CARECARD ₂ CHART₁ ₂ ₃ ₆ ₄ ₅ CCU ₄₅ ₆ ADHERE ₇ Mebazaa A ₈ Cardiology and Intensive Care Unit, Nippon Medical School Musashi-Kosugi

More information

EMS EMS W264

EMS EMS W264 ILCOR-CoSTR 10 Part 10 First Aid (2/5) (introduction) (definition of first aid) (medical emergencies) (injury emergencies) (environmental injuries) 2004 AHA ARC National First Aid Science Advisory Board

More information

4.4 R............................................. 13 4.5 q.............................................. 13 4.6 s....................................

4.4 R............................................. 13 4.5 q.............................................. 13 4.6 s.................................... 2014.04.12 2014.12.12 1 3 2 4 2.1............................................ 4 2.2 Einthoven triangle........................................ 4 2.3............................................ 4 2.4.............................................

More information

.K.C.h...C...ren

.K.C.h...C...ren 4 quality of life QOL QOL QOL 3 QOL 19 mmhg 16 mmhg 14 mmhg 1 2 7 20 30 QOL QOL QOL QOL QOL QOL QOL 4 1 1 1 2 1 2 3 1 2 4 2 2 1 2 2 2 2 1 2 3 QOL 3 2 1 1 5 1 1 2 1 Abraham Wise 1 Nd YAG 2 1 200 500 200

More information

スライド 1

スライド 1 1 2006 msv 2 2011 3 CT 2011 10mSv 10 40mSv 4 2012 217mSv 5 (CT) 2012 50 60mSv 6 2012 510mSv BRCA25 310 10mSv3% BRCA60-280% 3 5m Sv 1m Sv 12% . http://www.rea.or.jp/ire/pdf/report4.pdf 1.10 20 SMR 1.00

More information

大学論集第42号本文.indb

大学論集第42号本文.indb 42 2010 2011 3 279 295 COSO 281 COSO 1990 1 internal control 1 19962007, Internal Control Integrated Framework COSO COSO 282 42 2 2) the Committee of Sponsoring Organizations of the Treadway committee

More information

<95DB8C9288E397C389C88A E696E6462>

<95DB8C9288E397C389C88A E696E6462> 2011 Vol.60 No.2 p.138 147 Performance of the Japanese long-term care benefit: An International comparison based on OECD health data Mie MORIKAWA[1] Takako TSUTSUI[2] [1]National Institute of Public Health,

More information

日本臨床麻酔学会 vol.34

日本臨床麻酔学会 vol.34 392 Vol.34 No.3/May 2014 日本臨床麻酔学会第 32 回大会シンポジウム日臨麻会誌 Vol.34 No.3, 392 396, 2014 長期予後を考えた周術期管理とは? 周術期虚血性心疾患とニコランジル * 木下浩之 [ 要旨 ] ニコランジル投与が狭心症患者の長期予後を改善することは周知の事実である. 一方で, ニコランジル周術期投与の有用性については, 数少ない臨床研究で検討されているにすぎない.

More information

CQ 1,.,,.,,...,,,,,,.,,,,,,,MAO 2., 24,. A

CQ 1,.,,.,,...,,,,,,.,,,,,,,MAO 2., 24,. A CQ 1,.,,.,,...,,,,,,.,,,,,,,MAO 2., 24,. A 15 180 306 7,000 1 3 mg 103 92 89.3 60 60 100 173 28 16.2 3.52.92.3 1.7 1.7 1.7 2 64 78 80 3 ST 4 5 32 6 18 65 CQ 1 307 1 7,000 2006 ; 94 11 : 2149-2168. 2 2010

More information

_念3)医療2009_夏.indd

_念3)医療2009_夏.indd Evaluation of the Social Benefits of the Regional Medical System Based on Land Price Information -A Hedonic Valuation of the Sense of Relief Provided by Health Care Facilities- Takuma Sugahara Ph.D. Abstract

More information

GL改訂_野原班DST.indd

GL改訂_野原班DST.indd Quality of Life QOL HRQL Circulation Journal Vol. 71, Suppl. IV, 2007 1 HRQL ASO ASO ASO ASO 2 Circulation Journal Vol. 71, Suppl. IV, 2007 evidence based medicine a a b A B C,, A Quality of LifeQOL HDL

More information

The Heart Healthy Tocotrienol Complex Tocomin SupraBio

The Heart Healthy Tocotrienol Complex Tocomin SupraBio The Heart Healthy Tocotrienol Complex Tocomin SupraBio The Heart Healthy Tocotrienol Complex Tocomin SupraBio 1. Fact Sheet No. 317; World Health Organization (WHO), 2007 2. LLOYD-JONES D. et al. Circulation

More information

<30332D D8CB492982D FC95E490E690B62D8FAC8FBC96BE90E690B62E706466>

<30332D D8CB492982D FC95E490E690B62D8FAC8FBC96BE90E690B62E706466> A questionnaire survey on the use of placebo in clinical practice by nurses in Japan 1 1 2 2 1 4 1964 5, 6 1998 GCP 1 School of Nursing, Faculty of Medicine, Toho University 2Faculty of Medical Technology,

More information

<95DB8C9288E397C389C88A E696E6462>

<95DB8C9288E397C389C88A E696E6462> 2011 Vol.60 No.4 p.332 338 Usefulness of regional education program for dietary salt reduction: Self-monitoring of urinary salt excretion Kenichiro YASUTAKE[1] Kayoko SAWANO[1] Shoko YAMAGUCHI[1] Hiroko

More information

4703ALL01

4703ALL01 473201010 *** (1999) 16 2017 20023 2 1 2 1220 (1999a),(1999b) (1998), (2002) (2003)(1999)(2003) Conjoint Analysis Conjoint Analysis Willingness to PayStandard gamble Time trade-off Rating Scale Willingness

More information

Unknown

Unknown Journal of Breast and Thyroid Sonology Journal of Breast and Thyroid Sonology Vol.2, No.3 July 2013 Report The 30 th Meeting of Japan Association of Breast and Thyroid Sonology... 1 Department of Organ

More information

098青沼班DGfinal修正0506.indd

098青沼班DGfinal修正0506.indd 1 2011 Brugada QT 2005 2006 2007 Brugada Brugada 20 QT 70 2007 Brugada ICD ICD 5 2 QT Brugada 2012 QT QT QT Brugada Brugada 5 AHA/ACC ESC I II III A B C I II IIa IIb III A B C QT long QT syndrome LQTS

More information

Juntendo Medical Journal

Juntendo Medical Journal * Department of Health Science Health Sociology Section, Juntendo University School of Health and Sports Science, Chiba, Japan (WHO: Ottawa Charter for Health promotion, 1986.) (WHO: Bangkok Charter

More information

「長寿のためのコレステロール ガイドライン2010 年版」に対する声明

「長寿のためのコレステロール ガイドライン2010 年版」に対する声明 長寿のためのコレステロールガイドライン 2010 年版 に対する声明 平成 22 年 9 月 1 日に 脂質栄養学会 コレステロールガイドライン策定委員会 という組織から 標記 ガイドライン 1) が発表された この内容をめぐる一部のメディアの報道により 一般の方々のみならず 患者やその家族の方々の間にも コレステロールに関する認識に 混乱を招いている 日本動脈硬化学会は 動脈硬化性疾患予防ガイドライン

More information

gofman2.eps

gofman2.eps 2011 7 10 4 7 1 ICRP(2007) 5.7 10 2 Sv 1 1 13 (=4600 =11 =660 ) 10mSv 5.7 10 4 4600[] =2.6[] ICRP 0 1 licrp 1 2 1 DDREF ICRP(2007) (ICRP 2007, p.178) - (idem., p.174) 1Sv - (DDREF: dose and dose-rate effectiveness

More information

Web Stamps 96 KJ Stamps Web Vol 8, No 1, 2004

Web Stamps 96 KJ Stamps Web Vol 8, No 1, 2004 The Journal of the Japan Academy of Nursing Administration and Policies Vol 8, No 1, pp 43 _ 57, 2004 The Literature Review of the Japanese Nurses Job Satisfaction Research Which the Stamps-Ozaki Scale

More information

表 参照文献 ( 文献 ). 185, Expert Nurse. 1211, suppl, , CNS 2000, , , , 4

表 参照文献 ( 文献 ). 185, Expert Nurse. 1211, suppl, , CNS 2000, , , , 4 研究報告 がん看護専門看護師のコンサルテーション * についての概念分析 要旨 Walker Avant2005 CNS Key words はじめに 1996 2012 3 10 795 Certified Nurse SpecialistCNSCNS 327 1 CNS 2 CNS 3 4 5 6 CNS CNS 方法 Walker Avant 7 2012 8 1 2013 2 27 連絡先

More information

ON A FEW INFLUENCES OF THE DENTAL CARIES IN THE ELEMENTARY SCHOOL PUPIL BY Teruko KASAKURA, Naonobu IWAI, Sachio TAKADA Department of Hygiene, Nippon Dental College (Director: Prof. T. Niwa) The relationship

More information

<30388DE288E42E696E6464>

<30388DE288E42E696E6464> Doshisha Journal of Health & Sports Science, 1, 53-60, 2009 53 1 Effects of Step Exercise in Healthy Older People Tomoaki Sakai 1 The purpose of this study was to determine the effect of step exercise

More information

1) linisely, M. H. : Postburn Pathologic circulatory Physiology. F. A. Davis Co. philadelphia 1962, 2) James, G. W. et. al. : The anemia of thermal injury : Erythropoiesis and hemoglobin metabolism studied

More information

1-A-1[016-20].indd

1-A-1[016-20].indd A 急性冠症候群 1. 日本人の ACS は増えているのか? 欧米に比べて少ないのか? 1 序論 Acute coronary syndrome(acs) は急性心筋虚血による心臓突然死, 急性心筋梗塞, 不安定狭心症を含む疾患概念である. ここでは死亡率も高く疫学的知見が豊富な急性心筋梗塞を中心に述べる. わが国の急性心筋梗塞が増加しているのか, 国際的にみて少ないのかを知るための疫学指標はいくつか存在する.

More information

1 2 D- D- 1206 D- D- -2003 120 /2004 D-FDA GRAS D D- 3 5 5 D- 75 10g/kg 14 40 20 D-101520 90 1520 20%101520 1520 D- 5(D- 2300-6700mg//) () 2024 615 D- 41220g/kg/ 1220g/kg/ 20g/kg/ 1220g/kg/ () 50 D- 10%

More information

Ⅰ. Statistics Concerning Health Birthweight (1) Birthweight by year (2) Mean birthweight by prefecture, 2007-1997 (3) Percentage of births under 2,500g by prefecture, 2007-1997 Sex Ratio (4) Sex ratio

More information

v

v v CONTENTS 1 2 7 2 14 COLUMN 15 RAGEAGEs 21 COLUMN 22 26 COLUMN NADPH 28 32 COLUMN GLP1 36 39 COLUMN AGEs 44 46 54 COLUMN GWAS 55 59 3 66 COLUMN 69 COLUMN 1 2 71 vi 4 78 84 89 COLUMN GFR decliner 92 94

More information

臨床神経45-1.indb

臨床神経45-1.indb 59 Case of the Issue No. 9 carpal tunnel syndrome: CTS CTS CTS CTS nerve conduction study; NCS needle electromyography; nemg NCS carpal tunnel syndrome: CTS 1 CTS 4 CTS 45 65 1 3 2 CTS CTS 1999 American

More information

_’£”R‡Ù‡©

_’£”R‡Ù‡© 29 31 38 2008 31 1) 2) 2) 3) 2) 1) 2008 302008 12 Activities of Daily Living ADL ADL 42 ADL ADL 1990 QOL Quality of Life QOL 1 QOL // 2 Activity of Daily Living ADL Performance Status PS ADL 3 1) 2) 3)

More information

近年、心肺蘇生(CPR)における人工呼吸の必要性に疑問を投げかける報告が相次いだ

近年、心肺蘇生(CPR)における人工呼吸の必要性に疑問を投げかける報告が相次いだ 胸骨圧迫のみの CPR に関する ILCOR の潮流 背景アメリカ心臓協会 (American Heart Association:AHA) は 2008 年 4 月 突然に発症した成人の心停止症例において 心停止の場面を目撃した救助者が CPR の訓練を受けていない場合 あるいは訓練を受けていても胸骨圧迫の中断を必要最小限に留めた人工呼吸を行う自信がない場合には 胸骨圧迫のみの CPR(Hands-only

More information

26 1 : Self - reported Practices of Cancer Pain Management among Nurses in Tohoku University Hospital Hideyuki Hira

26 1 : Self - reported Practices of Cancer Pain Management among Nurses in Tohoku University Hospital Hideyuki Hira 26 1 : 35 45 2017 1 2 2 2 2 2 2 2 2 1 1 2 Self - reported Practices of Cancer Pain Management among Nurses in Tohoku University Hospital Hideyuki Hirayama 1, Yoko Nakajo 2, Akemi Saito 2, Rie Hatakeyama

More information

Effects of Diet Class on Overweight Middle-aged Women Analysis of Nutritional Intake Pattern YAMAGUCHI Shizue*, MATSUMOTO Tomoko**, MIMURA Kan-ichi***, ASAI Hitoshi****, OKUDA Toyoko***** * O saka Shin-ai

More information

P. 1 P9. Introducer P10. ) ) 2 P11. 1 P12. polytetrafluoroethylene 1 P13. P14. P15. 1 P16. twiddler syndrome 1 P1. h 141

P. 1 P9. Introducer P10. ) ) 2 P11. 1 P12. polytetrafluoroethylene 1 P13. P14. P15. 1 P16. twiddler syndrome 1 P1. h 141 ) ) A 1 ) ) P1. AAI ME P2. DDD MR HOCM 1 P3. middle cardiac vein P4. MRSA P5. ) P6. 319 1 P. 1 14:30 15:30 140 P. 1 P9. Introducer P10. ) ) 2 P11. 1 P12. polytetrafluoroethylene 1 P13. P14. P15. 1 P16.

More information

22●24頁●6-16▲救急外来▲.ppt

22●24頁●6-16▲救急外来▲.ppt No. 98 No. 62 No. 92 No. 60 No. 61 No. 99 GQM No.172 A B GRMRM RM 4B 5 No.337 No.357 No.359 No.112 No.200 151226 25 No. 31 1461 30mg/dl 0.15mg/l mg/dl 20-50 51-100 101-200 201-300 301-400 401-450- 10 No.201

More information

Fig. 1 Clinical findings and extent of inflammation area in female urethrocystitis Fig. 2 Classification and distribution of female patients with blad

Fig. 1 Clinical findings and extent of inflammation area in female urethrocystitis Fig. 2 Classification and distribution of female patients with blad Key words: Female with bladder irritability, Subjective symptoms, Pyuria, Bacteriuria Fig. 1 Clinical findings and extent of inflammation area in female urethrocystitis Fig. 2 Classification and distribution

More information

untitled

untitled Vol.4(2008) pp.41-52 1 1 2 3 1 1 1 2 3 19 12 20 Preliminary Studies of Robot Assisted Rehabilitation Using Commercially Available Entertainment Robots Toshihiro TETSUI 1 Eiichi OHKUBO 1 Noriko KATO 2 Shin

More information

2, 12 Figure 1 Various methods of measuring carotid stenosis via ultrasound examination. Figure 2 Incidence of vascular events in medical treatment pa

2, 12 Figure 1 Various methods of measuring carotid stenosis via ultrasound examination. Figure 2 Incidence of vascular events in medical treatment pa Online publication January 14, 2011 総 説 第 50 回 総 会 シンポジウム 5 日 本 脳 神 経 血 管 内 治 療 学 会 : 頭 頸 部 頭 蓋 内 血 管 に 対 する 血 行 再 建 術 頸 動 脈 狭 窄 症 の 内 科 治 療 要 旨 : pioglitazone EPA 80 unstable plaque MES CEA J Jpn Coll

More information

1 見出し1,12ポ,日本語ゴシック,英語Arial,段落後は6ポの設定です

1 見出し1,12ポ,日本語ゴシック,英語Arial,段落後は6ポの設定です 8. Page1 8. B 1 5) 6) 2099 2370 50 400 mg 19 (1) 1) (a) 78.9% 30/38 4 3 35.7% 5/14 71.4% 10/1485.7% 12/142 1 83.3% 5/63 2 1 1 1 8. Page2 (b) 2099 1897 82.4% 1562/1897 2 84.0% 1298/1545 3 2 80.4% 472/58779.0%

More information

AS No.4/2.™ƒfi⁄Dr.qx

AS No.4/2.™ƒfi⁄Dr.qx ArteriosclerosisAtherosclerosis ArteriosclerosisAtherosclerosis arteriosclerosis atherosclerosis arteriosclerosis arteriosclerosis arteriosclerosis Lakatta 1, 2 glycosaminoglycan 1. 3 Schlatmann080 1346-8375/03/400//JCLS

More information

- 1 -

- 1 - - 1 - 35:261-262 2005.12 35:153-154 2005.12-2 - 15500383 15-17 2006.3 [] 1 17(5):161-165 2005.5 32(3):130-134 2005.6 Synovial fringe 1 22(3):322 2005.10 Pancoast 56(13):1663-1666 2005.12 [] 22(5):788-795

More information